| Literature DB >> 31408339 |
Michael C Van Zandt1, G Erik Jagdmann1, Darren L Whitehouse1, Minkoo Ji1, Jennifer Savoy1, Olga Potapova2, Alexandra Cousido-Siah3, Andre Mitschler3, Eduardo I Howard4, Anna Marie Pyle2, Alberto D Podjarny3.
Abstract
Recent efforts to identify new highly potent arginase inhibitors have resulted in the discovery of a novel family of (3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid analogues with up to a 1000-fold increase in potency relative to the current standards, 2-amino-6-boronohexanoic acid (ABH) and N-hydroxy-nor-l-arginine (nor-NOHA). The lead candidate, with an N-2-amino-3-phenylpropyl substituent (NED-3238), example 43, inhibits arginase I and II with IC50 values of 1.3 and 8.1 nM, respectively. Herein, we report the design, synthesis, and structure-activity relationships for this novel series of inhibitors, along with X-ray crystallographic data for selected examples bound to human arginase II.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31408339 DOI: 10.1021/acs.jmedchem.9b00931
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446